ICU Medical, Inc. (ICUI)
| Market Cap | 5.20B |
| Revenue (ttm) | 1.28B |
| Net Income (ttm) | 103.26M |
| Shares Out | 21.20M |
| EPS (ttm) | 4.76 |
| PE Ratio | 51.02 |
| Forward PE | 21.93 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 88,990 |
| Open | 244.12 |
| Previous Close | 245.15 |
| Day's Range | 241.67 - 246.26 |
| 52-Week Range | 176.19 - 282.00 |
| Beta | 0.59 |
| Analysts | Buy |
| Price Target | 296.00 (+21.9%) |
| Est. Earnings Date | Nov 4, 2021 |
About ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana h...
Financial Performance
In 2020, ICU Medical's revenue was $1.27 billion, an increase of 0.38% compared to the previous year's $1.27 billion. Earnings were $86.87 million, a decrease of -14.02%.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for ICU Medical stock is "Buy." The 12-month stock price forecast is 296.00, which is an increase of 21.91% from the latest price.
News
ICU Medical Pulls Amino Acid IV Products After Foreign Substances Found In Batch
ICU Medical Inc (NASDAQ: ICUI), a California-based infusion therapy company, is voluntarily recalling one lot of an amino acid injection after reports of fibers, hair, and other particles of foreign mat...
Why ICU Medical Stock Is Jumping Today
A leading manufacturer of intravenous therapy solutions is about to get a lot bigger.
Why ICU Medical Shares Surged Today
ICU Medical (NASDAQ: ICUI) shares are trading higher after the company announced it will acquire Smiths Medical division from Smiths Group PLC for $2.35 billion in cash and stock. The Smiths Medical bus...
ICUI Stock: What Is the Huge News Sending ICU Medical Soaring 35% Today
Today, a big acquisition deal has sent shares of ICU Medical more than 30% higher as investors and speculators buy into ICUI stock. The post ICUI Stock: What Is the Huge News Sending ICU Medical Soaring...
Smiths Group Divests Its Medical Division To ICU Medical In $2.4B Deal
ICU Medical Inc (NASDAQ: ICUI) has agreed to acquire Smiths Group plc's Medical division in a transaction that will create an IV therapy company and simplify customer workflow. The Smiths Medical busin...
ICU Medical, Inc. to acquire Smiths Medical division from Smiths Group plc for $2.35 billion in cash and stock plus t...
The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products into ICU Medical creates a leading infusion therapy company with a stronger global reach
ICU Medical Issues a Voluntary Nationwide Recall of Aminosyn II 15%, An Amino Acid Injection, Sulfite Free IV Solutio...
LAKE FOREST, Ill., Sept. 3, 2021 /PRNewswire/ -- ICU Medical, Inc. is voluntarily recalling one lot (2,112 units) of Aminosyn II, 15%, An Amino Acid Injection, Sulfite Free intravenous (IV) solution to...
ICU Medical (ICUI) Q2 Earnings and Revenues Beat Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of 14.63% and 5.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
ICU Medical, Inc. Announces Second Quarter 2021 Results
Company Updated FY 2021 Guidance Company Updated FY 2021 Guidance
Earnings Preview: ICU Medical (ICUI) Q2 Earnings Expected to Decline
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical (ICUI) Q1 Earnings and Revenues Top Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of 5.88% and 4.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
ICU Medical, Inc. Announces First Quarter 2021 Results
SAN CLEMENTE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and crit...
Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Stocks To Buy Today As The Reopening Rotation Continues
As bond yields pop and the rotation out of tech into recovery plays continues, Q.ai's Artificial Intelligence has brought you today's top buys.
ICU Medical, Inc. Announces Fourth Quarter 2020 Results and Provides Fiscal Year 2021 Guidance
SAN CLEMENTE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...
ICU Medical, Inc. to Present at the Raymond James 42nd Annual Institutional Investors Conference
SAN CLEMENTE, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...
ICU Medical, Inc. to Present at the J.P. Morgan 39th Annual Healthcare Conference
SAN CLEMENTE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...
Here's Why This Under-The-Radar Value Stock Is A Long-Term Buy
This medical device company is a vital part of the backbone of hospital products utilized in the U.S. and around the world.
ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q3 2020 Results - Earnings Call Transcript
ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q3 2020 Results - Earnings Call Transcript
ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of 48.44% and 13.53%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
ICU Medical, Inc. Announces Time of Third Quarter 2020 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and cri...
ICU Medical, Inc. to Present at Morgan Stanley 18th Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and ...
ICU Medical (ICUI) Looks Good: Stock Adds 8.1% in Session
ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2020 Results - Earnings Call Transcript
ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2020 Results - Earnings Call Transcript